低侵襲手術器具市場 : 2029年までの世界予測

Report Overview

The minimally invasive surgical instruments market is projected to reach USD 49.9 Billion by 2029 from USD 31.7 Billion in 2024, at a CAGR of 9.5% during the forecast period.

低侵襲手術器具市場は、予測期間中のCAGR 9.5%で、2024年の317億米ドルから2029年までに499億米ドルに達すると予測されています。

Market expansion is propelled by factors such as the growing utilization of advanced robotics in Ambulatory Surgical Centers (ASCs), the rising global volume of surgical procedures, and the advantages of minimally invasive surgery (MIS) over traditional open techniques. Conversely, significant market consolidation among key players and the need for substantial capital investments pose notable obstacles to market growth.

“Robotic instruments segment accounted for the highest CAGR”
By product, the market is primarily segmented into handheld instruments, inflation devices, surgical scopes, cutting instruments, guiding devices, electrosurgical & electrocautery instruments, robotic instruments and other instruments. The handheld instruments segment accounted for the largest share of the minimally invasive surgical instruments in 2023. The substantial increase in market growth can be primarily attributed to the extensive utilization of both disposable and reusable electrosurgical instruments. Furthermore, advancements in the technology of electrosurgical instruments and the growing demand for cosmetic and plastic surgeries are driving the expansion of this sector.

“The non-robotic surgery segment accounted for the market share in the minimally invasive surgical instruments market, by technology, during the forecast period”
By technology, the market is primarily segmented into non-robotic surgery and robotic surgery. In 2023, non-robotic surgery accounted for the highest share of this market. The main factors propelling the growth of the market are the low cost of the non-robotic surgeries, no installation cost and rising geriatric population which believes in traditional surgeries. Additionally, surgeons often prefer the tactile feedback and direct control offered by non-robotic instruments, contributing to their continued prominence in the market.

“Cardiothoracic segment accounted for the highest share”
By type of surgery, the market is primarily segmented into cardiothoracic surgery, gastrointestinal surgery, orthopedic surgery, gynecological surgery, cosmetic & bariatric surgery, urological surgery, and other surgeries. The cardiothoracic surgery segment accounted for the largest share of the minimally invasive surgical instruments type of surgery market in 2023. The primary drivers of growth in this market are increased chronic diseases like diabetes which affects the cardiac health.
“Hospitals and specialty clinics segment accounted for the highest share”
By end user, the market is primarily segmented into hospitals and specialty clinics and ambulatory surgery centers. The hospitals and specialty clinics segment accounted for a larger share of the minimally invasive surgical instruments market in 2023. This can be credited to the significant volume of minimally invasive surgical procedures carried out in hospitals, facilitated by the presence of highly skilled healthcare professionals.

“Asia Pacific: The fastest-growing region in minimally invasive surgical instruments market”
The global minimally invasive surgical instruments market is segmented into North America, Europe, the Asia Pacific, Latin America, the Middle East & Africa and GCC Countries. Various factors are contributing to the growth of the market in the Asia-Pacific (APAC) region, including escalating healthcare expenditure, heightened government initiatives to raise awareness about early disease detection, rising per capita income, expansion of private-sector healthcare facilities into rural areas across several APAC nations, the increasing elderly population (accompanied by a surge in chronic conditions), and the existence of high-growth markets in the region. Moreover, the advantageous regulatory landscape and low labor costs in this region are anticipated to further drive market expansion.

Breakdown of supply-side primary interviews, by company type, designation, and region:
• By Company Type: Tier 1 (20%), Tier 2 (45%), and Tier 3 (35%)
• By Designation: C-level (30%), Director-level (20%), and Others (50%)
• By Region: North America (42%), Europe (31%), Asia- Pacific (20%), Latin America (4%), Middle East & Africa(2%) and GCC Countries (1%)

Lists of Companies Profiled in the Report:

• Medtronic PLC (US)
• Johnson & Johnson (US)
• Intuitive Surgical Inc. (US)
• Boston Scientific Corporation (US)
• Stryker Corporation (US)
• Abbott Laboratories, Inc. (US)
• B. Braun SE (Germany)
• Conmed Corporation (US)
• Smith + Nephew (UK)
• Zimmer Biomet Holdings, Inc. (US)
• Becton, Dickinson and Company (US)
• The Cooper Companies Inc. (US)
• Surgical Innovations Group PLC(UK)
• Koninklijke Philips N.V. (Netherlands)
• FUJIFILM Holdings Corporation(Japan)

Research Coverage
This research report categorizes the minimally invasive surgical instruments market by product, technology, type of surgery, end-user, and region. The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the minimally invasive surgical instruments market. A detailed analysis of the key industry players has been done to provide insights into their business overview; key strategies; product launch, approval, acquisition, agreement, expansion and recent developments associated with the minimally invasive surgical instruments market. Competitive analysis of upcoming startups in the minimally invasive surgical instruments market ecosystem is covered in this report.

Reasons to buy this report
The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall minimally invasive surgical instruments market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and to plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.

The report provides insights on the following pointers:
Analysis of key drivers (Increasing number of surgical procedures worldwide), restraints (Changing regulatory landscape in medical devices), opportunities (Improving healthcare infrastructure in emerging markets), and challenges (High degree of market consolidation) influencing the growth of the minimally invasive surgical instruments market.
• Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product launches in the minimally invasive surgical instruments market
• Market Development: Comprehensive information about lucrative markets – the report analyses the minimally invasive surgical instruments market across varied regions.
• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the minimally invasive surgical instruments market
• Competitive Assessment: In-depth assessment of market shares, growth strategies and service offerings of leading players like Medtronic PLC (US), Johnson & Johnson (US), Intuitive Surgical Inc. (US), Boston Scientific Corporation (US), Stryker Corporation (US). among others in minimally invasive surgical instruments market.

Table of Contents

1            INTRODUCTION            53

1.1         STUDY OBJECTIVES      53

1.2         MARKET DEFINITION   53

1.2.1      INCLUSIONS & EXCLUSIONS     54

1.3         STUDY SCOPE  55

1.3.1      MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SEGMENTATION           55

1.3.2      REGIONS COVERED      56

1.3.3      YEARS CONSIDERED     56

1.4         CURRENCY CONSIDERED          57

1.5         MARKET STAKEHOLDERS          57

1.6         SUMMARY OF CHANGES            57

1.7         RECESSION IMPACT      58

2            RESEARCH METHODOLOGY     59

2.1         RESEARCH DATA           59

FIGURE 1           MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET: RESEARCH DESIGN METHODOLOGY    59

2.1.1      SECONDARY DATA       60

2.1.1.1   Key data from secondary sources     60

2.1.2      PRIMARY DATA 61

2.1.2.1   Primary sources   62

2.1.2.2   Key data from primary sources         62

2.1.2.3   Key industry insights          63

2.1.2.4   Breakdown of primary interviews     64

FIGURE 2           BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS 64

FIGURE 3           BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION,  AND REGION  64

2.2         MARKET SIZE ESTIMATION       65

2.2.1      BOTTOM-UP APPROACH           65

2.2.1.1   Approach 1: Company revenue estimation approach    66

FIGURE 4           BOTTOM-UP APPROACH: COMPANY REVENUE ESTIMATION APPROACH       66

2.2.1.2   Approach 2: Presentations of companies and primary interviews              66

2.2.1.3   Growth forecast   66

2.2.1.4   CAGR projections             67

FIGURE 5           CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS   67

2.2.2      TOP-DOWN APPROACH             67

FIGURE 6           MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET: TOP-DOWN APPROACH             68

2.3         MARKET BREAKDOWN & DATA TRIANGULATION          68

FIGURE 7           DATA TRIANGULATION METHODOLOGY         69

2.4         MARKET SHARE             69

2.5         ASSUMPTIONS & LIMITATIONS 70

2.5.1      GROWTH RATE ASSUMPTIONS 70

2.5.2      LIMITATIONS   70

2.6         RISK ASSESSMENT         71

TABLE 1             RISK ASSESSMENT: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET            71

2.7         RECESSION IMPACT ANALYSIS 71

3            EXECUTIVE SUMMARY 73

FIGURE 8           MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY PRODUCT, 2024 VS. 2029 (USD MILLION)            73

FIGURE 9           MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY TECHNOLOGY, 2024 VS. 2029 (USD MILLION)    74

FIGURE 10         MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY TYPE OF SURGERY, 2024 VS. 2029 (USD MILLION)           74

FIGURE 11         MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY END USER,  2024 VS. 2029 (USD MILLION)          75

FIGURE 12         MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY REGION,  2024 VS. 2029 (USD MILLION)              76

4            PREMIUM INSIGHTS      77

4.1         MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET OVERVIEW              77

FIGURE 13         GROWING PREVALENCE OF TARGET DISEASES AND INCREASING NUMBER OF SURGERIES WORLDWIDE TO DRIVE MARKET GROWTH          77

4.2         MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SHARE, BY PRODUCT, 2024 VS. 2029             78

FIGURE 14         HANDHELD INSTRUMENTS SEGMENT TO CONTINUE TO DOMINATE MARKET  IN 2029  78

4.3         MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SHARE, BY TECHNOLOGY, 2024 VS. 2029     79

FIGURE 15         NON-ROBOTIC SURGERY SEGMENT TO ACCOUNT FOR LARGER MARKET SHARE IN 2029            79

4.4         MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SHARE, BY TYPE OF SURGERY, 2024 VS. 2029            80

FIGURE 16         CARDIOTHORACIC SURGERY SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD   80

4.5         MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET  SHARE, BY END USER, 2024 VS. 2029             81

FIGURE 17         HOSPITALS & SPECIALTY CLINICS TO DOMINATE MARKET  DURING FORECAST PERIOD     81

4.6         MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES         82

FIGURE 18         ASIA PACIFIC TO REGISTER THE HIGHEST GROWTH RATE IN THE MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET DURING THE FORECAST PERIOD       82

5            MARKET OVERVIEW     83

5.1         INTRODUCTION            83

5.2         MARKET DYNAMICS     83

FIGURE 19         MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES    83

5.2.1      DRIVERS            84

5.2.1.1   Increasing number of surgical procedures worldwide   84

5.2.1.2   Advantages of MIS over open surgeries          85

5.2.1.3   Increasing investments, funds, and grants by governments and other organizations worldwide            85

TABLE 2             MAJOR DEVELOPMENTS IN FUNDING ORGANIZATIONS              86

5.2.2      RESTRAINTS     87

5.2.2.1   Changing regulatory landscape in medical devices       87

5.2.2.2   High overhead cost of surgical procedures with limited reimbursement    88

5.2.3      OPPORTUNITIES           88

5.2.3.1   Improving healthcare infrastructure in emerging markets          88

5.2.3.2   Increasing number of ASCs              89

FIGURE 20         US: NUMBER OF AMBULATORY SURGERY CENTERS, 2012–2022              89

TABLE 3             MEDICARE FEE-FOR-SERVICE DIFFERENCES IN FACILITY FEE PAYMENTS,  ASCS VS. HOPDS, 2021      89

5.2.4      CHALLENGES   90

5.2.4.1   High degree of market consolidation 90

5.2.4.2   Product recalls witnessed by major market players       91

TABLE 4             LIST OF PRODUCT RECALLS     91

5.3         PRICING ANALYSIS        92

5.3.1      AVERAGE SELLING PRICE OF MINIMALLY INVASIVE SURGICAL INSTRUMENTS, BY PRODUCT   92

TABLE 5             AVERAGE SELLING PRICE OF MINIMALLY INVASIVE SURGICAL INSTRUMENTS, BY PRODUCT, 2021–2023            92

5.3.2      AVERAGE SELLING PRICE OF MINIMALLY INVASIVE SURGICAL INSTRUMENTS, BY REGION       93

TABLE 6             AVERAGE SELLING PRICE OF MINIMALLY INVASIVE SURGICAL INSTRUMENTS, BY REGION (2023)         93

5.4         PATENT ANALYSIS        94

FIGURE 21         PATENT ANALYSIS FOR MINIMALLY INVASIVE SURGICAL INSTRUMENTS (JANUARY 2014–DECEMBER 2023)           94

5.4.1      LIST OF MAJOR PATENTS          95

5.5         VALUE CHAIN ANALYSIS            96

FIGURE 22         MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET: VALUE CHAIN ANALYSIS            96

5.6         SUPPLY CHAIN ANALYSIS          97

FIGURE 23         MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET:  SUPPLY CHAIN ANALYSIS          98

5.7         TRADE ANALYSIS          99

5.7.1      TRADE ANALYSIS FOR NEEDLES, CATHETERS, AND CANNULAS 99

TABLE 7             IMPORT DATA FOR NEEDLES, CATHETERS, AND CANNULAS,  BY COUNTRY, 2019–2023 (USD MILLION)            99

TABLE 8             EXPORT DATA FOR NEEDLES, CATHETERS, AND CANNULAS, BY COUNTRY,  2019–2023 (USD MILLION)         99

5.8         ECOSYSTEM ANALYSIS 100

FIGURE 24         MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET: ECOSYSTEM ANALYSIS 100

TABLE 9             MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET: ROLE IN ECOSYSTEM    101

5.9         PORTER’S FIVE FORCES ANALYSIS         101

FIGURE 25         MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET: PORTER’S FIVE FORCES ANALYSIS         102

TABLE 10           MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET: PORTER’S FIVE FORCES ANALYSIS         102

5.9.1      THREAT OF NEW ENTRANTS    103

5.9.2      THREAT OF SUBSTITUTES         103

5.9.3      BARGAINING POWER OF BUYERS           103

5.9.4      BARGAINING POWER OF SUPPLIERS     103

5.9.5      INTENSITY OF COMPETITIVE RIVALRY 103

5.10       REGULATORY LANDSCAPE       103

5.10.1    REGULATORY SCENARIO           104

5.10.1.1 North America     104

5.10.1.1.1            US         104

TABLE 11           US FDA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS              105

5.10.1.1.2            Canada  105

5.10.1.2 Europe  105

5.10.1.3 Asia Pacific          106

5.10.1.3.1            China     106

TABLE 12           CHINA: CLASSIFICATION OF MEDICAL DEVICES             106

5.10.1.3.2            Japan     106

5.10.1.3.3            India      107

5.10.1.4 Latin America      107

5.10.1.4.1            Brazil     107

5.10.1.4.2            Mexico  107

5.10.1.5 Middle East         107

5.10.2    LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES,  AND OTHER ORGANIZATIONS          108

TABLE 13           NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS         108

TABLE 14           ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS         108

5.11       TECHNOLOGY ANALYSIS           109

5.11.1    KEY TECHNOLOGIES    109

5.11.1.1 Endoscopes         109

5.11.1.2 Laparoscopes       109

5.11.2    COMPLEMENTARY TECHNOLOGIES     109

5.11.2.1 Electrosurgical instruments              109

5.11.2.2 Robotic-assisted surgery    109

5.11.3    ADJACENT TECHNOLOGIES      110

5.11.3.1 Digital solutions  110

5.11.3.2 Medical/Surgical imaging  110

5.12       KEY CONFERENCES & EVENTS IN 2024–2025       110

TABLE 15           MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET: DETAILED LIST OF CONFERENCES & EVENTS   110

5.13       TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 111

5.13.1    REVENUE SHIFT & REVENUE POCKETS FOR MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET       111

FIGURE 26         REVENUE SHIFT IN MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET            112

5.14       KEY STAKEHOLDERS & BUYING CRITERIA          112

5.14.1    KEY STAKEHOLDERS IN BUYING PROCESS         112

FIGURE 27         INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF MINIMALLY INVASIVE SURGICAL INSTRUMENTS FOR END USERS          112

TABLE 16           INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF MINIMALLY INVASIVE SURGICAL INSTRUMENTS FOR END USERS (%)   113

5.14.2    BUYING CRITERIA         113

FIGURE 28         KEY BUYING CRITERIA OF MINIMALLY INVASIVE SURGICAL INSTRUMENTS FOR END USERS             113

TABLE 17           KEY BUYING CRITERIA OF MINIMALLY INVASIVE SURGICAL INSTRUMENTS  FOR END USERS           114

5.15       INVESTMENT & FUNDING SCENARIO    114

FIGURE 29         MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET: INVESTMENT & FUNDING SCENARIO    114

6            MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET,  BY PRODUCT         115

6.1         INTRODUCTION            116

TABLE 18           MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY PRODUCT,  2022–2029 (USD MILLION) 116

TABLE 19           MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY TYPE,  2022–2029 (MILLION UNITS)      117

6.2         HANDHELD INSTRUMENTS      117

TABLE 20           KEY PRODUCTS IN HANDHELD INSTRUMENTS MARKET              118

TABLE 21           MINIMALLY INVASIVE HANDHELD INSTRUMENTS MARKET, BY TYPE,  2022–2029 (USD MILLION)    118

TABLE 22           MINIMALLY INVASIVE HANDHELD INSTRUMENTS MARKET, BY REGION,  2022–2029 (USD MILLION)             119

TABLE 23           NORTH AMERICA: MINIMALLY INVASIVE HANDHELD INSTRUMENTS MARKET,  BY COUNTRY, 2022–2029 (USD MILLION)      119

TABLE 24           EUROPE: MINIMALLY INVASIVE HANDHELD INSTRUMENTS MARKET, BY COUNTRY,  2022–2029 (USD MILLION)      120

TABLE 25           ASIA PACIFIC: MINIMALLY INVASIVE HANDHELD INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)         120

TABLE 26           LATIN AMERICA: MINIMALLY INVASIVE HANDHELD INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)         121

6.2.1      GRASPERS         121

6.2.1.1   Increased patient safety and better reach provided by rotator graspers to drive market growth     121

TABLE 27           KEY PRODUCTS IN GRASPERS MARKET 122

TABLE 28           MINIMALLY INVASIVE GRASPERS MARKET, BY REGION, 2022–2029 (USD MILLION)     122

6.2.2      RETRACTORS/ELEVATORS        123

6.2.2.1   Growing markets for spinal, orthopedic, and endoscopic surgical procedures to support adoption of retractors/elevators        123

TABLE 29           KEY PRODUCTS IN RETRACTORS/ELEVATORS MARKET              123

TABLE 30           MINIMALLY INVASIVE RETRACTORS/ELEVATORS MARKET, BY REGION,  2022–2029 (USD MILLION)     124

6.2.3      SUTURING INSTRUMENTS         124

6.2.3.1   Need for skilled professionals for proper placement of sutures to challenge growth              124

TABLE 31           KEY PRODUCTS IN SUTURING INSTRUMENTS MARKET 125

TABLE 32           MINIMALLY INVASIVE SUTURING INSTRUMENTS MARKET, BY REGION,  2022–2029 (USD MILLION)     126

6.2.4      DILATORS         126

6.2.4.1   Safe and efficient surgical-site access to support adoption of dilators       126

TABLE 33           MINIMALLY INVASIVE DILATORS MARKET, BY REGION, 2022–2029 (USD MILLION)     127

6.2.5      OTHER HANDHELD INSTRUMENTS      127

TABLE 34           KEY PRODUCTS IN OTHER HANDHELD INSTRUMENTS MARKET            128

TABLE 35           OTHER MINIMALLY INVASIVE HANDHELD INSTRUMENTS MARKET, BY REGION,  2022–2029 (USD MILLION)          128

6.3         INFLATION DEVICES    129

TABLE 36           MINIMALLY INVASIVE INFLATION DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)          129

TABLE 37           MINIMALLY INVASIVE INFLATION DEVICES MARKET, BY REGION,  2022–2029 (USD MILLION)     130

TABLE 38           NORTH AMERICA: MINIMALLY INVASIVE INFLATION DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)         130

TABLE 39           EUROPE: MINIMALLY INVASIVE INFLATION DEVICES MARKET, BY COUNTRY,  2022–2029 (USD MILLION)         131

TABLE 40           ASIA PACIFIC: MINIMALLY INVASIVE INFLATION DEVICES MARKET, BY COUNTRY,  2022–2029 (USD MILLION)      131

TABLE 41           LATIN AMERICA: MINIMALLY INVASIVE INFLATION DEVICES MARKET, BY COUNTRY,  2022–2029 (USD MILLION)      132

6.3.1      BALLOONS       132

6.3.1.1   Large number of angioplasty procedures carried out across globe to drive market growth   132

TABLE 42           KEY PRODUCTS IN BALLOONS MARKET             133

TABLE 43           MINIMALLY INVASIVE BALLOONS MARKET, BY REGION, 2022–2029 (USD MILLION)     133

6.3.2      BALLOON INFLATION DEVICES             133

6.3.2.1   Growing adoption of balloon inflation devices to drive growth   133

TABLE 44           MINIMALLY INVASIVE BALLOON INFLATION DEVICES MARKET, BY REGION,  2022–2029 (USD MILLION)          134

6.4         SURGICAL SCOPES        134

TABLE 45           KEY PRODUCTS IN SURGICAL SCOPES MARKET             135

TABLE 46           MINIMALLY INVASIVE SURGICAL SCOPES MARKET, BY TYPE, 2022–2029 (USD MILLION)          135

TABLE 47           MINIMALLY INVASIVE SURGICAL SCOPES MARKET, BY TYPE, 2022–2029 (UNITS)         136

TABLE 48          MINIMALLY INVASIVE SURGICAL SCOPES MARKET, BY REGION,  2022–2029 (USD MILLION)          136

TABLE 49           NORTH AMERICA: MINIMALLY INVASIVE SURGICAL SCOPES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)         137

TABLE 50           EUROPE: MINIMALLY INVASIVE SURGICAL SCOPES MARKET, BY COUNTRY,  2022–2029 (USD MILLION)         137

TABLE 51           ASIA PACIFIC: MINIMALLY INVASIVE SURGICAL SCOPES MARKET, BY COUNTRY,  2022–2029 (USD MILLION)      138

TABLE 52           LATIN AMERICA: MINIMALLY INVASIVE SURGICAL SCOPES MARKET, BY COUNTRY,  2022–2029 (USD MILLION)      138

6.4.1      LAPAROSCOPES             139

6.4.1.1   Increasing number of laparoscopic surgeries and reduction in overall surgery cost to boost market growth      139

TABLE 53           KEY PRODUCTS IN LAPAROSCOPES MARKET    139

TABLE 54           MINIMALLY INVASIVE LAPAROSCOPES MARKET, BY REGION, 2022–2029 (USD MILLION)          140

6.4.2      UROLOGY ENDOSCOPES           140

6.4.2.1   Growing prevalence of urinary tract infections to drive market   140

TABLE 55           MINIMALLY INVASIVE UROLOGY ENDOSCOPES MARKET, BY REGION,  2022–2029 (USD MILLION)     141

6.4.3      ARTHROSCOPES            141

6.4.3.1   Increasing prevalence of rheumatoid arthritis to propel market growth    141

TABLE 56           KEY PRODUCTS IN ARTHROSCOPES MARKET   142

TABLE 57           MINIMALLY INVASIVE ARTHROSCOPES MARKET, BY REGION, 2022–2029 (USD MILLION)          142

6.4.4      NEUROENDSCOPES      143

6.4.4.1   Increasing prevalence of brain cancer to boost market  143

TABLE 58           MINIMALLY INVASIVE NEUROENDOSCOPES MARKET, BY REGION,  2022–2029 (USD MILLION)     144

6.4.5      OTHER SURGICAL SCOPES        144

TABLE 59           OTHER MINIMALLY INVASIVE SURGICAL SCOPES MARKET, BY REGION,  2022–2029 (USD MILLION)     145

6.5         CUTTING INSTRUMENTS           145

TABLE 60           KEY PRODUCTS IN CUTTING INSTRUMENTS MARKET  145

TABLE 61           MINIMALLY INVASIVE CUTTING INSTRUMENTS MARKET, BY TYPE,  2022–2029 (USD MILLION)          146

TABLE 62           MINIMALLY INVASIVE CUTTING INSTRUMENTS MARKET, BY REGION,  2022–2029 (USD MILLION)     146

TABLE 63           NORTH AMERICA: MINIMALLY INVASIVE CUTTING INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)         147

TABLE 64           EUROPE: MINIMALLY INVASIVE CUTTING INSTRUMENTS MARKET, BY COUNTRY,  2022–2029 (USD MILLION)      147

TABLE 65           ASIA PACIFIC: MINIMALLY INVASIVE CUTTING INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)         148

TABLE 66           LATIN AMERICA: MINIMALLY INVASIVE CUTTING INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)         148

6.5.1      TROCARS          148

6.5.1.1   Improved trocar designs to boost adoption     148

TABLE 67           KEY PRODUCTS IN TROCARS MARKET 149

TABLE 68           MINIMALLY INVASIVE TROCARS MARKET, BY REGION, 2022–2029 (USD MILLION)     149

6.5.2      OTHER CUTTING INSTRUMENTS           149

TABLE 69           KEY PRODUCTS IN OTHER CUTTING INSTRUMENTS MARKET              150

TABLE 70           OTHER MINIMALLY INVASIVE CUTTING INSTRUMENTS MARKET, BY REGION,  2022–2029 (USD MILLION)          151

6.6         GUIDING DEVICES        151

TABLE 71           KEY PRODUCTS IN GUIDING DEVICES MARKET             152

TABLE 72           MINIMALLY INVASIVE GUIDING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)          152

TABLE 73          MINIMALLY INVASIVE GUIDING DEVICES MARKET, BY REGION,  2022–2029 (USD MILLION)          153

TABLE 74           NORTH AMERICA: MINIMALLY INVASIVE GUIDING DEVICES MARKET, BY COUNTRY,  2022–2029 (USD MILLION)      153

TABLE 75           EUROPE: MINIMALLY INVASIVE GUIDING DEVICES MARKET, BY COUNTRY,  2022–2029 (USD MILLION)         154

TABLE 76           ASIA PACIFIC: MINIMALLY INVASIVE GUIDING DEVICES MARKET, BY COUNTRY,  2022–2029 (USD MILLION)      154

TABLE 77           LATIN AMERICA: MINIMALLY INVASIVE GUIDING DEVICES MARKET, BY COUNTRY,  2022–2029 (USD MILLION)      155

6.6.1      GUIDING CATHETERS  155

6.6.1.1   Availability of customized catheters for specific inventions to drive demand              155

TABLE 78           KEY PRODUCTS IN GUIDING CATHETERS MARKET       156

TABLE 79           MINIMALLY INVASIVE GUIDING CATHETERS MARKET, BY REGION,  2022–2029 (USD MILLION)     156

6.6.2      GUIDEWIRES    157

6.6.2.1   Growing adoption of guidewires to fuel market growth 157

TABLE 80           KEY PRODUCTS IN GUIDEWIRES MARKET         157

TABLE 81           MINIMALLY INVASIVE GUIDEWIRES MARKET, BY REGION, 2022–2029 (USD MILLION)          158

6.7         ELECTROSURGICAL & ELECTROCAUTERY INSTRUMENTS         158

TABLE 82           KEY PRODUCTS IN ELECTROSURGICAL & ELECTROCAUTERY INSTRUMENTS MARKET            159

TABLE 83           MINIMALLY INVASIVE ELECTROSURGICAL & ELECTROCAUTERY INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)          159

TABLE 84           MINIMALLY INVASIVE ELECTROSURGICAL & ELECTROCAUTERY INSTRUMENTS MARKET, BY REGION, 2022–2029 (USD MILLION)          160

TABLE 85           NORTH AMERICA: MINIMALLY INVASIVE ELECTROSURGICAL & ELECTROCAUTERY INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          160

TABLE 86           EUROPE: MINIMALLY INVASIVE ELECTROSURGICAL & ELECTROCAUTERY INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          161

TABLE 87           ASIA PACIFIC: MINIMALLY INVASIVE ELECTROSURGICAL & ELECTROCAUTERY INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          161

TABLE 88           LATIN AMERICA: MINIMALLY INVASIVE ELECTROSURGICAL & ELECTROCAUTERY INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          162

6.7.1      ELECTROSURGICAL INSTRUMENTS      162

6.7.1.1   Electrosurgical instruments to grow at highest CAGR during forecast period              162

TABLE 89           KEY PRODUCTS IN ELECTROSURGICAL INSTRUMENTS MARKET            163

TABLE 90           MINIMALLY INVASIVE ELECTROSURGICAL INSTRUMENTS MARKET, BY REGION,  2022–2029 (USD MILLION)          164

6.7.2      ELECTROCAUTERY DEVICES    165

6.7.2.1   Increasing number of plastic surgeries to drive market for electrocautery devices              165

TABLE 91           MINIMALLY INVASIVE ELECTROCAUTERY DEVICES MARKET, BY REGION,  2022–2029 (USD MILLION)             165

6.8         ROBOTIC INSTRUMENTS           166

6.8.1      GROWING POPULARITY OF ROBOTIC SURGERY TO PROPEL MARKET GROWTH          166

TABLE 92           KEY PRODUCTS IN ROBOTIC INSTRUMENTS MARKET  166

TABLE 93           MINIMALLY INVASIVE ROBOTIC INSTRUMENTS MARKET, BY REGION,  2022–2029 (USD MILLION)     167

TABLE 94           NORTH AMERICA: MINIMALLY INVASIVE ROBOTIC INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)         167

TABLE 95           EUROPE: MINIMALLY INVASIVE ROBOTIC INSTRUMENTS MARKET, BY COUNTRY,  2022–2029 (USD MILLION)      168

TABLE 96           ASIA PACIFIC: MINIMALLY INVASIVE ROBOTIC INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)         168

TABLE 97           LATIN AMERICA: MINIMALLY INVASIVE ROBOTIC INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)         169

6.9         OTHER PRODUCTS       169

TABLE 98           KEY PRODUCTS IN OTHER PRODUCTS MARKET            170

TABLE 99           OTHER MINIMALLY INVASIVE PRODUCTS MARKET, BY REGION,  2022–2029 (USD MILLION)     171

TABLE 100         NORTH AMERICA: OTHER MINIMALLY INVASIVE PRODUCTS MARKET, BY COUNTRY,  2022–2029 (USD MILLION)      171

TABLE 101         EUROPE: OTHER MINIMALLY INVASIVE PRODUCTS MARKET, BY COUNTRY,  2022–2029 (USD MILLION)         172

TABLE 102         ASIA PACIFIC: OTHER MINIMALLY INVASIVE PRODUCTS MARKET, BY COUNTRY,  2022–2029 (USD MILLION)      172

TABLE 103         LATIN AMERICA: OTHER MINIMALLY INVASIVE PRODUCTS MARKET, BY COUNTRY,  2022–2029 (USD MILLION)      173

7            MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET,  BY TECHNOLOGY 174

7.1         INTRODUCTION            175

TABLE 104         MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY TECHNOLOGY,  2022–2029 (USD MILLION)       175

7.2         NON-ROBOTIC SURGERY           175

7.2.1      INCREASING ADOPTION OF MIS SURGERIES TO PROPEL MARKET GROWTH          175

TABLE 105         MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET FOR NON-ROBOTIC SURGERY, BY REGION, 2022–2029 (USD MILLION)           176

TABLE 106         NORTH AMERICA: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET FOR NON-ROBOTIC SURGERY, BY COUNTRY, 2022–2029 (USD MILLION)     176

TABLE 107         EUROPE: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET FOR NON-ROBOTIC SURGERY, BY COUNTRY, 2022–2029 (USD MILLION)          177

TABLE 108         ASIA PACIFIC: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET FOR NON-ROBOTIC SURGERY, BY COUNTRY, 2022–2029 (USD MILLION)          177

TABLE 109         LATIN AMERICA: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET FOR NON-ROBOTIC SURGERY, BY COUNTRY, 2022–2029 (USD MILLION)     178

7.3         ROBOTIC SURGERY       178

7.3.1      ADVANTAGES ASSOCIATED WITH ROBOTIC-ASSISTED SURGERY TO SUPPORT MARKET GROWTH    178

TABLE 110         AUSTRALIA AND NEW ZEALAND: ROBOTIC-ASSISTED PROCEDURES, BY SPECIALTY, 2018–2022 (NUMBER OF PROCEDURES)   179

TABLE 111         MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET FOR ROBOTIC SURGERY, BY REGION, 2022–2029 (USD MILLION)       179

TABLE 112         NORTH AMERICA: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET FOR ROBOTIC SURGERY, BY COUNTRY, 2022–2029 (USD MILLION) 180

TABLE 113         EUROPE: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET FOR ROBOTIC SURGERY, BY COUNTRY, 2022–2029 (USD MILLION)              180

TABLE 114         ASIA PACIFIC: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET FOR ROBOTIC SURGERY, BY COUNTRY, 2022–2029 (USD MILLION)              181

TABLE 115         LATIN AMERICA: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET FOR ROBOTIC SURGERY, BY COUNTRY, 2022–2029 (USD MILLION) 181

8            MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY TYPE OF SURGERY           182

8.1         INTRODUCTION            183

TABLE 116         MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY TYPE OF SURGERY,  2022–2029 (USD MILLION) 183

8.2         CARDIOTHORACIC SURGERY   183

8.2.1      GROWING PREVALENCE OF CARDIOVASCULAR DISEASES TO DRIVE MARKET GROWTH        183

TABLE 117         MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET FOR CARDIOTHORACIC SURGERY, BY REGION, 2022–2029 (USD MILLION)    184

TABLE 118         NORTH AMERICA: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET FOR CARDIOTHORACIC SURGERY, BY COUNTRY, 2022–2029 (USD MILLION)          185

TABLE 119         EUROPE: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET FOR CARDIOTHORACIC SURGERY, BY COUNTRY, 2022–2029 (USD MILLION)          185

TABLE 120         ASIA PACIFIC: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET FOR CARDIOTHORACIC SURGERY, BY COUNTRY, 2022–2029 (USD MILLION)          186

TABLE 121         LATIN AMERICA: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET FOR CARDIOTHORACIC SURGERY, BY COUNTRY, 2022–2029 (USD MILLION)          186

8.3         GASTROINTESTINAL SURGERY 186

8.3.1      GROWING BURDEN OF COLORECTAL CANCER TO SUPPORT MARKET GROWTH          186

TABLE 122         MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET FOR GASTROINTESTINAL SURGERY, BY REGION, 2022–2029 (USD MILLION) 187

TABLE 123         NORTH AMERICA: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET FOR GASTROINTESTINAL SURGERY, BY COUNTRY, 2022–2029 (USD MILLION)          188

TABLE 124         EUROPE: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET FOR GASTROINTESTINAL SURGERY, BY COUNTRY, 2022–2029 (USD MILLION)          188

TABLE 125         ASIA PACIFIC: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET FOR GASTROINTESTINAL SURGERY, BY COUNTRY, 2022–2029 (USD MILLION)          189

TABLE 126         LATIN AMERICA: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET FOR GASTROINTESTINAL SURGERY, BY COUNTRY, 2022–2029 (USD MILLION)          189

8.4         ORTHOPEDIC SURGERY            189

8.4.1      INCREASING GERIATRIC POPULATION AND SUBSEQUENT INCREASE IN ORTHOPEDIC AILMENTS TO BOOST MARKET           189

TABLE 127         MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET FOR ORTHOPEDIC SURGERY,  BY REGION, 2022–2029 (USD MILLION)          190

TABLE 128         NORTH AMERICA: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET FOR ORTHOPEDIC SURGERY, BY COUNTRY, 2022–2029 (USD MILLION) 191

TABLE 129         EUROPE: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET FOR ORTHOPEDIC SURGERY, BY COUNTRY, 2022–2029 (USD MILLION)          191

TABLE 130         ASIA PACIFIC: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET FOR ORTHOPEDIC SURGERY, BY COUNTRY, 2022–2029 (USD MILLION)          192

TABLE 131         LATIN AMERICA: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET FOR ORTHOPEDIC SURGERY, BY COUNTRY, 2022–2029 (USD MILLION) 192

8.5         GYNECOLOGICAL SURGERY     192

8.5.1      GROWING NUMBER OF LAPAROSCOPIC HYSTERECTOMIES TO SUPPORT MARKET GROWTH    192

TABLE 132         MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET FOR GYNECOLOGICAL SURGERY, BY REGION, 2022–2029 (USD MILLION)      193

TABLE 133         NORTH AMERICA: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET FOR GYNECOLOGICAL SURGERY, BY COUNTRY, 2022–2029 (USD MILLION)     194

TABLE 134         EUROPE: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET FOR GYNECOLOGICAL SURGERY, BY COUNTRY, 2022–2029 (USD MILLION)          194

TABLE 135         ASIA PACIFIC: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET FOR GYNECOLOGICAL SURGERY, BY COUNTRY, 2022–2029 (USD MILLION)          195

TABLE 136         LATIN AMERICA: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET FOR GYNECOLOGICAL SURGERY, BY COUNTRY, 2022–2029 (USD MILLION)     195

8.6         BARIATRIC SURGERY    195

8.6.1      INCREASING PREVALENCE OF OBESITY TO FUEL GROWTH      195

TABLE 137         MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET FOR BARIATRIC SURGERY,  BY REGION, 2022–2029 (USD MILLION)  196

TABLE 138         NORTH AMERICA: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET FOR BARIATRIC SURGERY, BY COUNTRY, 2022–2029 (USD MILLION) 196

TABLE 139         EUROPE: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET FOR BARIATRIC SURGERY, BY COUNTRY, 2022–2029 (USD MILLION)              197

TABLE 140         ASIA PACIFIC: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET FOR BARIATRIC SURGERY, BY COUNTRY, 2022–2029 (USD MILLION)              197

TABLE 141         LATIN AMERICA: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET FOR BARIATRIC SURGERY, BY COUNTRY, 2022–2029 (USD MILLION) 198

8.7         COSMETIC SURGERY    198

8.7.1      GROWING PREFERENCE FOR COSMETIC PROCEDURES TO PROPEL MARKET            198

TABLE 142         MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET FOR COSMETIC SURGERY,  BY REGION, 2022–2029 (USD MILLION)  199

TABLE 143         NORTH AMERICA: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET FOR COSMETIC SURGERY, BY COUNTRY, 2022–2029 (USD MILLION) 199

TABLE 144         EUROPE: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET FOR COSMETIC SURGERY, BY COUNTRY, 2022–2029 (USD MILLION)              200

TABLE 145         ASIA PACIFIC: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET FOR COSMETIC SURGERY, BY COUNTRY, 2022–2029 (USD MILLION)              200

TABLE 146         LATIN AMERICA: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET FOR COSMETIC SURGERY, BY COUNTRY, 2022–2029 (USD MILLION) 201

8.8         UROLOGICAL SURGERY             201

8.8.1      COST BENEFITS OF LAPAROSCOPIC CYSTOSCOPY TO BOOST ADOPTION       201

TABLE 147         MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET FOR UROLOGICAL SURGERY,  BY REGION, 2022–2029 (USD MILLION)           202

TABLE 148         NORTH AMERICA: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET FOR UROLOGICAL SURGERY, BY COUNTRY, 2022–2029 (USD MILLION) 202

TABLE 149         EUROPE: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET FOR UROLOGICAL SURGERY, BY COUNTRY, 2022–2029 (USD MILLION)          203

TABLE 150         ASIA PACIFIC: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET FOR UROLOGICAL SURGERY, BY COUNTRY, 2022–2029 (USD MILLION)          203

TABLE 151         LATIN AMERICA: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET FOR UROLOGICAL SURGERY, BY COUNTRY, 2022–2029 (USD MILLION) 204

8.9         OTHER SURGERIES       204

TABLE 152         MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET FOR OTHER SURGERIES,  BY REGION, 2022–2029 (USD MILLION)     205

TABLE 153         NORTH AMERICA: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET FOR OTHER SURGERIES, BY COUNTRY, 2022–2029 (USD MILLION) 205

TABLE 154         EUROPE: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET FOR OTHER SURGERIES, BY COUNTRY, 2022–2029 (USD MILLION)              206

TABLE 155         ASIA PACIFIC: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET FOR OTHER SURGERIES, BY COUNTRY, 2022–2029 (USD MILLION)              206

TABLE 156         LATIN AMERICA: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET FOR OTHER SURGERIES, BY COUNTRY, 2022–2029 (USD MILLION) 207

9            MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET,  BY END USER    208

9.1         INTRODUCTION            209

TABLE 157         MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY END USER,  2022–2029 (USD MILLION) 209

9.2         HOSPITALS & SPECIALTY CLINICS         209

9.2.1      GROWING NUMBER OF HOSPITALS AND INCREASING GOVERNMENT INVESTMENTS TO DRIVE MARKET GROWTH    209

TABLE 158         MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET FOR HOSPITALS & SPECIALTY CLINICS, BY REGION, 2022–2029 (USD MILLION)              210

TABLE 159         NORTH AMERICA: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET FOR HOSPITALS & SPECIALTY CLINICS, BY COUNTRY, 2022–2029 (USD MILLION)          211

TABLE 160         EUROPE: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET FOR HOSPITALS & SPECIALTY CLINICS, BY COUNTRY, 2022–2029 (USD MILLION)          211

TABLE 161         ASIA PACIFIC: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET FOR HOSPITALS & SPECIALTY CLINICS, BY COUNTRY, 2022–2029 (USD MILLION)          212

TABLE 162         LATIN AMERICA: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET FOR HOSPITALS & SPECIALTY CLINICS, BY COUNTRY, 2022–2029 (USD MILLION)          212

9.3         AMBULATORY SURGERY CENTERS        212

9.3.1      LOWER COST AND SHORTER PATIENT STAYS TO PROPEL MARKET GROWTH          212

TABLE 163         MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET FOR AMBULATORY SURGERY CENTERS, BY REGION, 2022–2029 (USD MILLION)              213

TABLE 164         NORTH AMERICA: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET FOR AMBULATORY SURGERY CENTERS, BY COUNTRY, 2022–2029 (USD MILLION)          214

TABLE 165         EUROPE: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET FOR AMBULATORY SURGERY CENTERS, BY COUNTRY, 2022–2029 (USD MILLION) 214

TABLE 166         ASIA PACIFIC: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET FOR AMBULATORY SURGERY CENTERS, BY COUNTRY, 2022–2029 (USD MILLION) 215

TABLE 167         LATIN AMERICA: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET FOR AMBULATORY SURGERY CENTERS, BY COUNTRY, 2022–2029 (USD MILLION)          215

10          MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET,  BY REGION             216

10.1       INTRODUCTION            217

TABLE 168         GLOBAL NUMBER OF SURGICAL PROCEDURES, 2021     217

TABLE 169         MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY REGION,  2022–2029 (USD MILLION)     218

10.2       NORTH AMERICA          218

FIGURE 30         NORTH AMERICA: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SNAPSHOT     219

TABLE 170         NORTH AMERICA: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)         220

TABLE 171         NORTH AMERICA: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)         220

TABLE 172         NORTH AMERICA: MINIMALLY INVASIVE HANDHELD INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)    221

TABLE 173         NORTH AMERICA: MINIMALLY INVASIVE INFLATION DEVICES MARKET, BY TYPE,  2022–2029 (USD MILLION) 221

TABLE 174         NORTH AMERICA: MINIMALLY INVASIVE SURGICAL SCOPES MARKET, BY TYPE,  2022–2029 (USD MILLION) 222

TABLE 175         NORTH AMERICA: MINIMALLY INVASIVE CUTTING INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)    222

TABLE 176         NORTH AMERICA: MINIMALLY INVASIVE GUIDING DEVICES MARKET, BY TYPE,  2022–2029 (USD MILLION) 222

TABLE 177         NORTH AMERICA: MINIMALLY INVASIVE ELECTROSURGICAL & ELECTROCAUTERY INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)          223

TABLE 178         NORTH AMERICA: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION) 223

TABLE 179         NORTH AMERICA: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY TYPE OF SURGERY, 2022–2029 (USD MILLION)              224

TABLE 180         NORTH AMERICA: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET,  BY END USER, 2022–2029 (USD MILLION)      224

10.2.1    NORTH AMERICA: RECESSION IMPACT 224

10.2.2    US         225

10.2.2.1 US to dominate North American market during forecast period 225

TABLE 181         US: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)            226

TABLE 182         US: MINIMALLY INVASIVE HANDHELD INSTRUMENTS MARKET, BY TYPE,  2022–2029 (USD MILLION) 227

TABLE 183         US: MINIMALLY INVASIVE INFLATION DEVICES MARKET, BY TYPE,  2022–2029 (USD MILLION)          227

TABLE 184         US: MINIMALLY INVASIVE SURGICAL SCOPES MARKET, BY TYPE, 2022–2029 (USD MILLION)             228

TABLE 185         US: MINIMALLY INVASIVE CUTTING INSTRUMENTS MARKET, BY TYPE,  2022–2029 (USD MILLION)    228

TABLE 186         US: MINIMALLY INVASIVE GUIDING DEVICES MARKET, BY TYPE,  2022–2029 (USD MILLION)          228

TABLE 187         US: MINIMALLY INVASIVE ELECTROSURGICAL & ELECTROCAUTERY INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)          229

TABLE 188         US: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY TECHNOLOGY,  2022–2029 (USD MILLION) 229

TABLE 189         US: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY TYPE OF SURGERY, 2022–2029 (USD MILLION)           230

TABLE 190         US: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY END USER,  2022–2029 (USD MILLION)         230

10.2.3    CANADA            231

10.2.3.1 Increasing prevalence of cancer to favor market growth             231

TABLE 191         CANADA: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY PRODUCT,  2022–2029 (USD MILLION)      232

TABLE 192         CANADA: MINIMALLY INVASIVE HANDHELD INSTRUMENTS MARKET, BY TYPE,  2022–2029 (USD MILLION) 232

TABLE 193        CANADA: MINIMALLY INVASIVE INFLATION DEVICES MARKET, BY TYPE,  2022–2029 (USD MILLION)    233

TABLE 194         CANADA: MINIMALLY INVASIVE SURGICAL SCOPES MARKET, BY TYPE,  2022–2029 (USD MILLION)    233

TABLE 195         CANADA: MINIMALLY INVASIVE CUTTING INSTRUMENTS MARKET, BY TYPE,  2022–2029 (USD MILLION) 233

TABLE 196         CANADA: MINIMALLY INVASIVE GUIDING DEVICES MARKET, BY TYPE,  2022–2029 (USD MILLION)    234

TABLE 197         CANADA: MINIMALLY INVASIVE ELECTROSURGICAL & ELECTROCAUTERY INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)          234

TABLE 198         CANADA: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION) 234

TABLE 199         CANADA: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY TYPE OF SURGERY, 2022–2029 (USD MILLION)        235

TABLE 200         CANADA: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY END USER,  2022–2029 (USD MILLION)      235

10.3       EUROPE             235

TABLE 201         EUROPE: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)         236

TABLE 202         EUROPE: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY PRODUCT,  2022–2029 (USD MILLION)      237

TABLE 203         EUROPE: MINIMALLY INVASIVE HANDHELD INSTRUMENTS MARKET, BY TYPE,  2022–2029 (USD MILLION) 237

TABLE 204         EUROPE: MINIMALLY INVASIVE INFLATION DEVICES MARKET, BY TYPE,  2022–2029 (USD MILLION)    238

TABLE 205         EUROPE: MINIMALLY INVASIVE SURGICAL SCOPES MARKET, BY TYPE,  2022–2029 (USD MILLION)    238

TABLE 206         EUROPE: MINIMALLY INVASIVE CUTTING INSTRUMENTS MARKET, BY TYPE,  2022–2029 (USD MILLION) 238

TABLE 207         EUROPE: MINIMALLY INVASIVE GUIDING DEVICES MARKET, BY TYPE,  2022–2029 (USD MILLION)    239

TABLE 208         EUROPE: MINIMALLY INVASIVE ELECTROSURGICAL & ELECTROCAUTERY INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)          239

TABLE 209         EUROPE: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION) 239

TABLE 210         EUROPE: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY TYPE OF SURGERY, 2022–2029 (USD MILLION)        240

TABLE 211         EUROPE: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY END USER,  2022–2029 (USD MILLION)      240

10.3.1    EUROPE: RECESSION IMPACT   240

10.3.2    GERMANY         241

10.3.2.1 Rising healthcare expenses in Germany to boost use of MIS instruments  241

TABLE 212         GERMANY: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)        242

TABLE 213         GERMANY: MINIMALLY INVASIVE HANDHELD INSTRUMENTS MARKET, BY TYPE,  2022–2029 (USD MILLION) 242

TABLE 214         GERMANY: MINIMALLY INVASIVE INFLATION DEVICES MARKET, BY TYPE,  2022–2029 (USD MILLION) 243

TABLE 215         GERMANY: MINIMALLY INVASIVE SURGICAL SCOPES MARKET, BY TYPE,  2022–2029 (USD MILLION)    243

TABLE 216         GERMANY: MINIMALLY INVASIVE CUTTING INSTRUMENTS MARKET, BY TYPE,  2022–2029 (USD MILLION) 243

TABLE 217         GERMANY: MINIMALLY INVASIVE GUIDING DEVICES MARKET, BY TYPE,  2022–2029 (USD MILLION)    244

TABLE 218         GERMANY: MINIMALLY INVASIVE ELECTROSURGICAL & ELECTROCAUTERY INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)          244

TABLE 219         GERMANY: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION) 244

TABLE 220         GERMANY: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY TYPE OF SURGERY, 2022–2029 (USD MILLION)        245

TABLE 221         GERMANY: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY END USER, 2022–2029 (USD MILLION)         245

10.3.3    UK         245

10.3.3.1 High incidence of cancer in UK to boost adoption of MIS instruments     245

TABLE 222         UK: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY PRODUCT,  2022–2029 (USD MILLION)         246

TABLE 223         UK: MINIMALLY INVASIVE HANDHELD INSTRUMENTS MARKET, BY TYPE,  2022–2029 (USD MILLION) 247

TABLE 224         UK: MINIMALLY INVASIVE INFLATION DEVICES MARKET, BY TYPE,  2022–2029 (USD MILLION)          247

TABLE 225         UK: MINIMALLY INVASIVE SURGICAL SCOPES MARKET, BY TYPE,  2022–2029 (USD MILLION)          248

TABLE 226         UK: MINIMALLY INVASIVE CUTTING INSTRUMENTS MARKET, BY TYPE,  2022–2029 (USD MILLION)    248

TABLE 227         UK: MINIMALLY INVASIVE GUIDING DEVICES MARKET, BY TYPE,  2022–2029 (USD MILLION)          248

TABLE 228         UK: MINIMALLY INVASIVE ELECTROSURGICAL & ELECTROCAUTERY INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)          249

TABLE 229         UK: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY TECHNOLOGY,  2022–2029 (USD MILLION) 249

TABLE 230         UK: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY TYPE OF SURGERY, 2022–2029 (USD MILLION)           250

TABLE 231         UK: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY END USER,  2022–2029 (USD MILLION)         250

10.3.4    FRANCE             250

10.3.4.1 Increasing number of surgeries in France to drive market growth             250

TABLE 232         FRANCE: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY PRODUCT,  2022–2029 (USD MILLION)      251

TABLE 233         FRANCE: MINIMALLY INVASIVE HANDHELD INSTRUMENTS MARKET, BY TYPE,  2022–2029 (USD MILLION) 252

TABLE 234         FRANCE: MINIMALLY INVASIVE INFLATION DEVICES MARKET, BY TYPE,  2022–2029 (USD MILLION)    252

TABLE 235         FRANCE: MINIMALLY INVASIVE SURGICAL SCOPES MARKET, BY TYPE,  2022–2029 (USD MILLION)    253

TABLE 236         FRANCE: MINIMALLY INVASIVE CUTTING INSTRUMENTS MARKET, BY TYPE,  2022–2029 (USD MILLION) 253

TABLE 237         FRANCE: MINIMALLY INVASIVE GUIDING DEVICES MARKET, BY TYPE,  2022–2029 (USD MILLION)    253

TABLE 238         FRANCE: MINIMALLY INVASIVE ELECTROSURGICAL & ELECTROCAUTERY INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)          254

TABLE 239         FRANCE: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION) 254

TABLE 240         FRANCE: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY TYPE OF SURGERY, 2022–2029 (USD MILLION)        255

TABLE 241         FRANCE: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY END USER,  2022–2029 (USD MILLION)      255

10.3.5    ITALY   255

10.3.5.1 Increasing incidence of cancer to support market growth in Italy              255

TABLE 242         ITALY: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY PRODUCT,  2022–2029 (USD MILLION)      256

TABLE 243         ITALY: MINIMALLY INVASIVE HANDHELD INSTRUMENTS MARKET, BY TYPE,  2022–2029 (USD MILLION) 257

TABLE 244         ITALY: MINIMALLY INVASIVE INFLATION DEVICES MARKET, BY TYPE,  2022–2029 (USD MILLION)    257

TABLE 245         ITALY: MINIMALLY INVASIVE SURGICAL SCOPES MARKET, BY TYPE,  2022–2029 (USD MILLION)          258

TABLE 246         ITALY: MINIMALLY INVASIVE CUTTING INSTRUMENTS MARKET, BY TYPE,  2022–2029 (USD MILLION) 258

TABLE 247         ITALY: MINIMALLY INVASIVE GUIDING DEVICES MARKET, BY TYPE,  2022–2029 (USD MILLION)          258

TABLE 248         ITALY: MINIMALLY INVASIVE ELECTROSURGICAL & ELECTROCAUTERY INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)          259

TABLE 249         ITALY: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY TECHNOLOGY,  2022–2029 (USD MILLION)            259

TABLE 250         ITALY: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY TYPE OF SURGERY, 2022–2029 (USD MILLION)        260

TABLE 251         ITALY: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY END USER, 2022–2029 (USD MILLION)         260

10.3.6    SPAIN   260

10.3.6.1 Increasing incidence of CVD to boost adoption of MIS 260

TABLE 252         SPAIN: MACROECONOMIC INDICATORS            261

TABLE 253         SPAIN: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY PRODUCT,  2022–2029 (USD MILLION)      261

TABLE 254         SPAIN: MINIMALLY INVASIVE HANDHELD INSTRUMENTS MARKET, BY TYPE,  2022–2029 (USD MILLION) 262

TABLE 255         SPAIN: MINIMALLY INVASIVE INFLATION DEVICES MARKET, BY TYPE,  2022–2029 (USD MILLION)    262

TABLE 256         SPAIN: MINIMALLY INVASIVE SURGICAL SCOPES MARKET, BY TYPE,  2022–2029 (USD MILLION)          263

TABLE 257         SPAIN: MINIMALLY INVASIVE CUTTING INSTRUMENTS MARKET, BY TYPE,  2022–2029 (USD MILLION) 263

TABLE 258         SPAIN: MINIMALLY INVASIVE GUIDING DEVICES MARKET, BY TYPE,  2022–2029 (USD MILLION)          263

TABLE 259         SPAIN: MINIMALLY INVASIVE ELECTROSURGICAL & ELECTROCAUTERY INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)          264

TABLE 260         SPAIN: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION) 264

TABLE 261         SPAIN: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY TYPE OF SURGERY, 2022–2029 (USD MILLION)        265

TABLE 262         SPAIN: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY END USER,  2022–2029 (USD MILLION)      265

10.3.7    REST OF EUROPE           265

TABLE 263         REST OF EUROPE: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)         266

TABLE 264         REST OF EUROPE: MINIMALLY INVASIVE HANDHELD INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)    267

TABLE 265         REST OF EUROPE: MINIMALLY INVASIVE INFLATION DEVICES MARKET, BY TYPE,  2022–2029 (USD MILLION) 267

TABLE 266         REST OF EUROPE: MINIMALLY INVASIVE SURGICAL SCOPES MARKET, BY TYPE,  2022–2029 (USD MILLION) 268

TABLE 267         REST OF EUROPE: MINIMALLY INVASIVE CUTTING INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)    268

TABLE 268         REST OF EUROPE: MINIMALLY INVASIVE GUIDING DEVICES MARKET, BY TYPE,  2022–2029 (USD MILLION) 268

TABLE 269         REST OF EUROPE: MINIMALLY INVASIVE ELECTROSURGICAL & ELECTROCAUTERY INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)          269

TABLE 270         REST OF EUROPE: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET,  BY TECHNOLOGY, 2022–2029 (USD MILLION)              269

TABLE 271         REST OF EUROPE: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY TYPE OF SURGERY, 2022–2029 (USD MILLION)              270

TABLE 272         REST OF EUROPE: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY END USER, 2022–2029 (USD MILLION)         270

10.4       ASIA PACIFIC    270

FIGURE 31         ASIA PACIFIC: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SNAPSHOT     271

TABLE 273         ASIA PACIFIC: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)         272

TABLE 274         ASIA PACIFIC: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)        272

TABLE 275         ASIA PACIFIC: MINIMALLY INVASIVE HANDHELD INSTRUMENTS MARKET, BY TYPE,  2022–2029 (USD MILLION) 273

TABLE 276         ASIA PACIFIC: MINIMALLY INVASIVE INFLATION DEVICES MARKET, BY TYPE,  2022–2029 (USD MILLION) 273

TABLE 277         ASIA PACIFIC: MINIMALLY INVASIVE SURGICAL SCOPES MARKET, BY TYPE,  2022–2029 (USD MILLION) 274

TABLE 278         ASIA PACIFIC: MINIMALLY INVASIVE CUTTING INSTRUMENTS MARKET, BY TYPE,  2022–2029 (USD MILLION) 274

TABLE 279         ASIA PACIFIC: MINIMALLY INVASIVE GUIDING DEVICES MARKET, BY TYPE,  2022–2029 (USD MILLION) 274

TABLE 280         ASIA PACIFIC: MINIMALLY INVASIVE ELECTROSURGICAL & ELECTROCAUTERY INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)          275

TABLE 281         ASIA PACIFIC: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION) 275

TABLE 282         ASIA PACIFIC: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY TYPE OF SURGERY, 2022–2029 (USD MILLION)        276

TABLE 283         ASIA PACIFIC: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY END USER, 2022–2029 (USD MILLION)         276

10.4.1    ASIA PACIFIC: RECESSION IMPACT        276

10.4.2    CHINA  277

10.4.2.1 Large population in China to drive market     277

TABLE 284         CHINA: MACROECONOMIC INDICATORS           278

TABLE 285         CHINA: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY PRODUCT,  2022–2029 (USD MILLION)      278

TABLE 286         CHINA: MINIMALLY INVASIVE HANDHELD INSTRUMENTS MARKET, BY TYPE,  2022–2029 (USD MILLION) 279

TABLE 287         CHINA: MINIMALLY INVASIVE INFLATION DEVICES MARKET, BY TYPE,  2022–2029 (USD MILLION)    279

TABLE 288         CHINA: MINIMALLY INVASIVE SURGICAL SCOPES MARKET, BY TYPE,  2022–2029 (USD MILLION)          280

TABLE 289         CHINA: MINIMALLY INVASIVE CUTTING INSTRUMENTS MARKET, BY TYPE,  2022–2029 (USD MILLION) 280

TABLE 290         CHINA: MINIMALLY INVASIVE GUIDING DEVICES MARKET, BY TYPE,  2022–2029 (USD MILLION)          280

TABLE 291         CHINA: MINIMALLY INVASIVE ELECTROSURGICAL & ELECTROCAUTERY INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)          281

TABLE 292         CHINA: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION) 281

TABLE 293         CHINA: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY TYPE OF SURGERY, 2022–2029 (USD MILLION)        282

TABLE 294         CHINA: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY END USER,  2022–2029 (USD MILLION)      282

10.4.3    JAPAN  282

10.4.3.1 Rising geriatric population in Japan to increase prevalence of chronic conditions              282

TABLE 295         JAPAN: MACROECONOMIC INDICATORS            283

TABLE 296         JAPAN: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY PRODUCT,  2022–2029 (USD MILLION)      284

TABLE 297         JAPAN: MINIMALLY INVASIVE HANDHELD INSTRUMENTS MARKET, BY TYPE,  2022–2029 (USD MILLION) 284

TABLE 298         JAPAN: MINIMALLY INVASIVE INFLATION DEVICES MARKET, BY TYPE,  2022–2029 (USD MILLION)    285

TABLE 299         JAPAN: MINIMALLY INVASIVE SURGICAL SCOPES MARKET, BY TYPE,  2022–2029 (USD MILLION)          285

TABLE 300         JAPAN: MINIMALLY INVASIVE CUTTING INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)    285

TABLE 301         JAPAN: MINIMALLY INVASIVE GUIDING DEVICES MARKET, BY TYPE,  2022–2029 (USD MILLION)          286

TABLE 302         JAPAN: MINIMALLY INVASIVE ELECTROSURGICAL & ELECTROCAUTERY INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)          286

TABLE 303         JAPAN: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION) 286

TABLE 304         JAPAN: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY TYPE OF SURGERY, 2022–2029 (USD MILLION)        287

TABLE 305         JAPAN: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY END USER,  2022–2029 (USD MILLION)      287

10.4.4    INDIA   288

10.4.4.1 Healthcare infrastructure improvements and increasing geriatric population to drive market growth in India            288

TABLE 306         INDIA: MACROECONOMIC INDICATORS            288

TABLE 307         INDIA: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY PRODUCT,  2022–2029 (USD MILLION)      289

TABLE 308         INDIA: MINIMALLY INVASIVE HANDHELD INSTRUMENTS MARKET, BY TYPE,  2022–2029 (USD MILLION) 289

TABLE 309         INDIA: MINIMALLY INVASIVE INFLATION DEVICES MARKET, BY TYPE,  2022–2029 (USD MILLION)    290

TABLE 310         INDIA: MINIMALLY INVASIVE SURGICAL SCOPES MARKET, BY TYPE,  2022–2029 (USD MILLION)          290

TABLE 311         INDIA: MINIMALLY INVASIVE CUTTING INSTRUMENTS MARKET, BY TYPE,  2022–2029 (USD MILLION) 290

TABLE 312         INDIA: MINIMALLY INVASIVE GUIDING DEVICES MARKET, BY TYPE,  2022–2029 (USD MILLION)          291

TABLE 313         INDIA: MINIMALLY INVASIVE ELECTROSURGICAL & ELECTROCAUTERY INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)          291

TABLE 314         INDIA: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY TECHNOLOGY,  2022–2029 (USD MILLION)            291

TABLE 315         INDIA: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY TYPE OF SURGERY, 2022–2029 (USD MILLION)        292

TABLE 316         INDIA: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY END USER,  2022–2029 (USD MILLION)      292

10.4.5    REST OF ASIA PACIFIC  292

TABLE 317         REST OF ASIA PACIFIC: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET,  BY PRODUCT, 2022–2029 (USD MILLION)      293

TABLE 318         REST OF ASIA PACIFIC: MINIMALLY INVASIVE HANDHELD INSTRUMENTS MARKET,  BY TYPE, 2022–2029 (USD MILLION) 294

TABLE 319         REST OF ASIA PACIFIC: MINIMALLY INVASIVE INFLATION DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 294

TABLE 320         REST OF ASIA PACIFIC: MINIMALLY INVASIVE SURGICAL SCOPES MARKET, BY TYPE, 2022–2029 (USD MILLION)   295

TABLE 321         REST OF ASIA PACIFIC: MINIMALLY INVASIVE CUTTING INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)    295

TABLE 322         REST OF ASIA PACIFIC: MINIMALLY INVASIVE GUIDING DEVICES MARKET, BY TYPE,  2022–2029 (USD MILLION)            295

TABLE 323         REST OF ASIA PACIFIC: MINIMALLY INVASIVE ELECTROSURGICAL & ELECTROCAUTERY INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)          296

TABLE 324         REST OF ASIA PACIFIC: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET,  BY TECHNOLOGY, 2022–2029 (USD MILLION)              296

TABLE 325         REST OF ASIA PACIFIC: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY TYPE OF SURGERY, 2022–2029 (USD MILLION)              297

TABLE 326         REST OF ASIA PACIFIC: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET,  BY END USER, 2022–2029 (USD MILLION)      297

10.5       LATIN AMERICA             298

TABLE 327         LATIN AMERICA: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)         298

TABLE 328         LATIN AMERICA: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)         299

TABLE 329         LATIN AMERICA: MINIMALLY INVASIVE HANDHELD INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)    299

TABLE 330         LATIN AMERICA: MINIMALLY INVASIVE INFLATION DEVICES MARKET, BY TYPE,  2022–2029 (USD MILLION) 300

TABLE 331         LATIN AMERICA: MINIMALLY INVASIVE SURGICAL SCOPES MARKET, BY TYPE,  2022–2029 (USD MILLION) 300

TABLE 332         LATIN AMERICA: MINIMALLY INVASIVE CUTTING INSTRUMENTS MARKET, BY TYPE,  2022–2029 (USD MILLION) 300

TABLE 333         LATIN AMERICA: MINIMALLY INVASIVE GUIDING DEVICES MARKET, BY TYPE,  2022–2029 (USD MILLION) 301

TABLE 334         LATIN AMERICA: MINIMALLY INVASIVE ELECTROSURGICAL & ELECTROCAUTERY INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)          301

TABLE 335         LATIN AMERICA: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET,  BY TECHNOLOGY, 2022–2029 (USD MILLION)              301

TABLE 336         LATIN AMERICA: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY TYPE OF SURGERY, 2022–2029 (USD MILLION)              302

TABLE 337         LATIN AMERICA: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY END USER, 2022–2029 (USD MILLION)         302

10.5.1    LATIN AMERICA: RECESSION IMPACT   302

10.5.2    BRAZIL 303

10.5.2.1 Healthcare infrastructure improvements and increasing cancer incidence to drive market growth     303

TABLE 338         BRAZIL: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY PRODUCT,  2022–2029 (USD MILLION)      304

TABLE 339         BRAZIL: MINIMALLY INVASIVE HANDHELD INSTRUMENTS MARKET, BY TYPE,  2022–2029 (USD MILLION) 304

TABLE 340         BRAZIL: MINIMALLY INVASIVE INFLATION DEVICES MARKET, BY TYPE,  2022–2029 (USD MILLION)    305

TABLE 341         BRAZIL: MINIMALLY INVASIVE SURGICAL SCOPES MARKET, BY TYPE,  2022–2029 (USD MILLION)          305

TABLE 342         BRAZIL: MINIMALLY INVASIVE CUTTING INSTRUMENTS MARKET, BY TYPE,  2022–2029 (USD MILLION) 305

TABLE 343         BRAZIL: MINIMALLY INVASIVE GUIDING DEVICES MARKET, BY TYPE,  2022–2029 (USD MILLION)          306

TABLE 344         BRAZIL: MINIMALLY INVASIVE ELECTROSURGICAL & ELECTROCAUTERY INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)          306

TABLE 345         BRAZIL: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION) 306

TABLE 346         BRAZIL: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY TYPE OF SURGERY, 2022–2029 (USD MILLION)        307

TABLE 347         BRAZIL: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY END USER,  2022–2029 (USD MILLION)      307

10.5.3    MEXICO             307

10.5.3.1 Growing medical tourism to drive market growth         307

TABLE 348         MEXICO: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)        308

TABLE 349         MEXICO: MINIMALLY INVASIVE HANDHELD INSTRUMENTS MARKET, BY TYPE,  2022–2029 (USD MILLION) 309

TABLE 350         MEXICO: MINIMALLY INVASIVE INFLATION DEVICES MARKET, BY TYPE,  2022–2029 (USD MILLION)    309

TABLE 351         MEXICO: MINIMALLY INVASIVE SURGICAL SCOPES MARKET, BY TYPE,  2022–2029 (USD MILLION)    310

TABLE 352         MEXICO: MINIMALLY INVASIVE CUTTING INSTRUMENTS MARKET, BY TYPE,  2022–2029 (USD MILLION) 310

TABLE 353         MEXICO: MINIMALLY INVASIVE GUIDING DEVICES MARKET, BY TYPE,  2022–2029 (USD MILLION)    310

TABLE 354         MEXICO: MINIMALLY INVASIVE ELECTROSURGICAL & ELECTROCAUTERY INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)          311

TABLE 355         MEXICO: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION) 311

TABLE 356         MEXICO: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY TYPE OF SURGERY, 2022–2029 (USD MILLION)        312

TABLE 357         MEXICO: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY END USER,  2022–2029 (USD MILLION)      312

10.5.4    REST OF LATIN AMERICA          312

TABLE 358         REST OF LATIN AMERICA: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET,  BY PRODUCT, 2022–2029 (USD MILLION)      313

TABLE 359         REST OF LATIN AMERICA: MINIMALLY INVASIVE HANDHELD INSTRUMENTS MARKET,  BY TYPE, 2022–2029 (USD MILLION) 313

TABLE 360         REST OF LATIN AMERICA: MINIMALLY INVASIVE INFLATION DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 314

TABLE 361         REST OF LATIN AMERICA: MINIMALLY INVASIVE SURGICAL SCOPES MARKET, BY TYPE, 2022–2029 (USD MILLION)   314

TABLE 362         REST OF LATIN AMERICA: MINIMALLY INVASIVE CUTTING INSTRUMENTS MARKET,  BY TYPE, 2022–2029 (USD MILLION) 314

TABLE 363         REST OF LATIN AMERICA: MINIMALLY INVASIVE GUIDING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 315

TABLE 364         REST OF LATIN AMERICA: MINIMALLY INVASIVE ELECTROSURGICAL & ELECTROCAUTERY INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)          315

TABLE 365         REST OF LATIN AMERICA: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET,  BY TECHNOLOGY, 2022–2029 (USD MILLION)              315

TABLE 366         REST OF LATIN AMERICA: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET,  BY TYPE OF SURGERY, 2022–2029 (USD MILLION)              316

TABLE 367         REST OF LATIN AMERICA: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET,  BY END USER, 2022–2029 (USD MILLION)      316

10.6       MIDDLE EAST & AFRICA             317

10.6.1    INCREASING HEALTHCARE EXPENDITURE TO BOOST MARKET              317

TABLE 368         MIDDLE EAST & AFRICA: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET,  BY PRODUCT, 2022–2029 (USD MILLION)      318

TABLE 369         MIDDLE EAST & AFRICA: MINIMALLY INVASIVE HANDHELD INSTRUMENTS MARKET,  BY TYPE, 2022–2029 (USD MILLION) 318

TABLE 370         MIDDLE EAST & AFRICA: MINIMALLY INVASIVE INFLATION DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 319

TABLE 371         MIDDLE EAST & AFRICA: MINIMALLY INVASIVE SURGICAL SCOPES MARKET,  BY TYPE, 2022–2029 (USD MILLION) 319

TABLE 372         MIDDLE EAST & AFRICA: MINIMALLY INVASIVE CUTTING INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)    319

TABLE 373         MIDDLE EAST & AFRICA: MINIMALLY INVASIVE GUIDING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 320

TABLE 374         MIDDLE EAST & AFRICA: MINIMALLY INVASIVE ELECTROSURGICAL & ELECTROCAUTERY INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)          320

TABLE 375         MIDDLE EAST & AFRICA: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET,  BY TECHNOLOGY, 2022–2029 (USD MILLION)              320

TABLE 376         MIDDLE EAST & AFRICA: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET,  BY TYPE OF SURGERY, 2022–2029 (USD MILLION)              321

TABLE 377         MIDDLE EAST & AFRICA: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET,  BY END USER, 2022–2029 (USD MILLION)      321

10.6.2    MIDDLE EAST & AFRICA: RECESSION IMPACT   321

10.7       GCC COUNTRIES           322

10.7.1    SUPPORTIVE GOVERNMENT INITIATIVES TO FUEL GROWTH   322

TABLE 378         GCC COUNTRIES: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)         322

TABLE 379         GCC COUNTRIES: MINIMALLY INVASIVE HANDHELD INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)    323

TABLE 380         GCC COUNTRIES: MINIMALLY INVASIVE INFLATION DEVICES MARKET, BY TYPE,  2022–2029 (USD MILLION) 323

TABLE 381         GCC COUNTRIES: MINIMALLY INVASIVE SURGICAL SCOPES MARKET, BY TYPE,  2022–2029 (USD MILLION) 324

TABLE 382         GCC COUNTRIES: MINIMALLY INVASIVE CUTTING INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)    324

TABLE 383         GCC COUNTRIES: MINIMALLY INVASIVE GUIDING DEVICES MARKET, BY TYPE,  2022–2029 (USD MILLION) 324

TABLE 384         GCC COUNTRIES: MINIMALLY INVASIVE ELECTROSURGICAL & ELECTROCAUTERY INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)          325

TABLE 385         GCC COUNTRIES: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET,  BY TECHNOLOGY, 2022–2029 (USD MILLION)              325

TABLE 386         GCC COUNTRIES: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET,  BY TYPE OF SURGERY, 2022–2029 (USD MILLION)              326

TABLE 387         GCC COUNTRIES: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY END USER, 2022–2029 (USD MILLION)         326

10.7.2    GCC COUNTRIES: RECESSION IMPACT 327

11          COMPETITIVE LANDSCAPE       328

11.1       OVERVIEW        328

11.2       KEY PLAYER STRATEGY/RIGHT TO WIN             328

11.2.1    OVERVIEW OF STRATEGIES DEPLOYED BY PLAYERS IN MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET   329

TABLE 388         MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET: STRATEGIES ADOPTED 329

11.3       REVENUE ANALYSIS      331

FIGURE 32         REVENUE ANALYSIS OF KEY PLAYERS IN MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, 2018–2023  331

11.4       MARKET SHARE ANALYSIS         331

FIGURE 33         MARKET SHARE ANALYSIS OF KEY PLAYERS IN MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, 2023       332

TABLE 389         MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET: DEGREE OF COMPETITION       332

11.5       COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023   333

11.5.1    LIST OF EVALUATED VENDORS             333

11.5.2    STARS  333

11.5.3    EMERGING LEADERS    333

11.5.4    PERVASIVE PLAYERS     334

11.5.5    PARTICIPANTS 334

FIGURE 34         MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023 334

11.5.6    COMPANY FOOTPRINT: KEY PLAYERS, 2023      335

11.5.6.1 Company footprint            335

FIGURE 35         MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET: COMPANY FOOTPRINT 335

11.5.6.2 Region footprint  335

TABLE 390         MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET: REGION FOOTPRINT    335

11.5.6.3 Technology footprint         336

TABLE 391         MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET: TECHNOLOGY FOOTPRINT      336

11.5.6.4 Type of surgery footprint   336

TABLE 392         MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET: TYPE OF SURGERY FOOTPRINT             336

11.6       COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023          337

11.6.1    PROGRESSIVE COMPANIES       337

11.6.2    RESPONSIVE COMPANIES          337

11.6.3    DYNAMIC COMPANIES 337

11.6.4    STARTING BLOCKS       337

FIGURE 36         MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023        338

11.6.5    COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023             339

TABLE 393         MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET: DETAILED LIST OF KEY STARTUPS/SMES           339

TABLE 394         MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SMES   339

11.7       COMPANY VALUATION & FINANCIAL METRICS 340

FIGURE 37         EV/EBITDA OF KEY VENDORS   340

FIGURE 38         YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF  KEY VENDORS           340

11.8       BRAND/PRODUCT COMPARISON          341

FIGURE 39         MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET: PRODUCT/BRAND COMPARISON          341

11.8.1    MEDTRONIC PLC           341

11.8.2    JOHNSON & JOHNSON  341

11.8.3    STRYKER CORPORATION           342

11.9       COMPETITIVE SCENARIO          342

11.9.1    PRODUCT LAUNCHES & APPROVALS    342

TABLE 395         MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–APRIL 2024            342

11.9.2    DEALS  343

TABLE 396         MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET: DEALS,  JANUARY 2021–APRIL 2024       343

11.9.3    EXPANSIONS    344

TABLE 397         MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET: EXPANSIONS, JANUARY 2021–APRIL 2024            344

12          COMPANY PROFILES    345

12.1       KEY PLAYERS   345

(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*

12.1.1    MEDTRONIC PLC           345

TABLE 398         MEDTRONIC PLC: COMPANY OVERVIEW           345

FIGURE 40         MEDTRONIC PLC: COMPANY SNAPSHOT (2023)             346

TABLE 399         MEDTRONIC PLC: PRODUCTS OFFERED            346

TABLE 400         MEDTRONIC PLC: PRODUCT LAUNCHES & APPROVALS,

JANUARY 2021–APRIL 2024         349

12.1.2    JOHNSON & JOHNSON  351

TABLE 401         JOHNSON & JOHNSON: COMPANY OVERVIEW  351

FIGURE 41         JOHNSON & JOHNSON: COMPANY SNAPSHOT (2023)    352

TABLE 402         JOHNSON & JOHNSON: PRODUCTS OFFERED   352

TABLE 403         JOHNSON & JOHNSON: PRODUCT LAUNCHES & APPROVALS,

JANUARY 2021–APRIL 2024         355

12.1.3    INTUITIVE SURGICAL, INC.        357

TABLE 404         INTUITIVE SURGICAL, INC.: BUSINESS OVERVIEW         357

FIGURE 42         INTUITIVE SURGICAL, INC.: COMPANY SNAPSHOT (2023)              358

TABLE 405         INTUITIVE SURGICAL, INC.: PRODUCTS OFFERED         359

TABLE 406         INTUITIVE SURGICALS, INC.: PRODUCT APPROVALS,

JANUARY 2021–APRIL 2024         360

12.1.4    BOSTON SCIENTIFIC CORPORATION    362

TABLE 407         BOSTON SCIENTIFIC CORPORATION: BUSINESS OVERVIEW              362

FIGURE 43         BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2023)   363

TABLE 408         BOSTON SCIENTIFIC CORPORATION: PRODUCTS OFFERED              364

TABLE 409         BOSTON SCIENTIFIC CORPORATION: PRODUCT APPROVALS, JANUARY 2021–APRIL 2024         366

TABLE 410         BOSTON SCIENTIFIC CORPORATION: DEALS, JANUARY 2021–APRIL 2024        367

12.1.5    STRYKER CORPORATION           369

TABLE 411         STRYKER CORPORATION: BUSINESS OVERVIEW             369

FIGURE 44         STRYKER CORPORATION: COMPANY SNAPSHOT (2023)              370

TABLE 412         STRYKER CORPORATION: PRODUCTS OFFERED            370

12.1.6    ABBOTT LABORATORIES, INC.  373

TABLE 413         ABBOTT LABORATORIES, INC.: BUSINESS OVERVIEW   373

FIGURE 45         ABBOTT LABORATORIES, INC.: COMPANY SNAPSHOT (2023)              374

TABLE 414         ABBOTT LABORATORIES, INC.: PRODUCTS OFFERED   374

TABLE 415         ABBOTT LABORATORIES, INC.: DEALS, JANUARY 2021–APRIL 2024      375

12.1.7    SMITH+NEPHEW           376

TABLE 416         SMITH+NEPHEW: BUSINESS OVERVIEW             376

FIGURE 46         SMITH+NEPHEW: COMPANY SNAPSHOT (2023) 377

TABLE 417         SMITH+NEPHEW: PRODUCTS OFFERED             377

TABLE 418         SMITH+NEPHEW: PRODUCT LAUNCHES, JANUARY 2021–APRIL 2024      379

12.1.8    B. BRAUN SE     380

TABLE 419         B. BRAUN SE: BUSINESS OVERVIEW       380

FIGURE 47         B. BRAUN SE: COMPANY SNAPSHOT (2023)        381

TABLE 420         B. BRAUN SE: PRODUCTS OFFERED       382

12.1.9    BECTON, DICKINSON AND COMPANY  384

TABLE 421         BECTON, DICKINSON AND COMPANY: BUSINESS OVERVIEW              384

FIGURE 48         BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2023)   385

TABLE 422         BECTON, DICKINSON AND COMPANY: PRODUCTS OFFERED              385

TABLE 423         BECTON, DICKINSON AND COMPANY: EXPANSIONS,

JANUARY 2021–APRIL 2024         386

12.1.10  CONMED CORPORATION          387

TABLE 424         CONMED CORPORATION: BUSINESS OVERVIEW            387

FIGURE 49         CONMED CORPORATION: COMPANY SNAPSHOT (2023)              388

TABLE 425         CONMED CORPORATION: PRODUCTS OFFERED            388

12.1.11  ZIMMER BIOMET HOLDINGS, INC.         392

TABLE 426         ZIMMER BIOMET HOLDINGS, INC.: BUSINESS OVERVIEW              392

FIGURE 50         ZIMMER BIOMET HOLDINGS, INC.: COMPANY SNAPSHOT (2023)   393

TABLE 427         ZIMMER BIOMET HOLDINGS, INC.: PRODUCTS OFFERED              394

12.1.12  THE COOPER COMPANIES, INC.             395

TABLE 428         THE COOPER COMPANIES, INC.: BUSINESS OVERVIEW 395

FIGURE 51         THE COOPER COMPANIES, INC.: COMPANY SNAPSHOT (2023)              396

TABLE 429         THE COOPER COMPANIES, INC.: PRODUCTS OFFERED 397

TABLE 430         THE COOPER COMPANIES, INC.: DEALS, JANUARY 2021–APRIL 2024      398

12.1.13  KONINKLIJKE PHILIPS N.V.        399

TABLE 431         KONINKLIJKE PHILIPS N.V.: BUSINESS OVERVIEW          399

FIGURE 52         KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2022)              400

TABLE 432         KONINKLIJKE PHILIPS N.V.: PRODUCTS OFFERED         400

TABLE 433         KONINKLIJKE PHILIPS N.V.: PRODUCT APPROVALS, JANUARY 2021–APRIL 2024             401

TABLE 434         KONINKLIJKE PHILIPS N.V.: DEALS, JANUARY 2021–APRIL 2024              401

12.1.14  SURGICAL INNOVATIONS GROUP PLC  402

TABLE 435         SURGICAL INNOVATIONS GROUP PLC: BUSINESS OVERVIEW              402

FIGURE 53         SURGICAL INNOVATIONS GROUP PLC: COMPANY SNAPSHOT (2022)   402

TABLE 436         SURGICAL INNOVATIONS GROUP PLC: PRODUCTS OFFERED              403

12.1.15  FUJIFILM HOLDINGS CORPORATION    404

TABLE 437         FUJIFILM HOLDINGS CORPORATION: BUSINESS OVERVIEW              404

FIGURE 54         FUJIFILM HOLDING CORPORATION: COMPANY SNAPSHOT (2022)   405

TABLE 438         FUJIFILM HOLDINGS CORPORATION: PRODUCTS OFFERED              405

TABLE 439         FUJIFILM HOLDINGS CORPORATION: PRODUCT LAUNCHES, JANUARY 2021–APRIL 2024         406

12.2       OTHER PLAYERS           407

12.2.1    HOYA CORPORATION  407

TABLE 440         HOYA CORPORATION: COMPANY OVERVIEW   407

12.2.2    KARL STORZ SE & CO. KG           409

TABLE 441         KARL STORZ SE & CO. KG: COMPANY OVERVIEW           409

12.2.3    APPLIED MEDICAL RESOURCES CORPORATION             410

TABLE 442         APPLIED MEDICAL RESOURCES CORPORATION: COMPANY OVERVIEW        410

12.2.4    KLS MARTIN GROUP     411

TABLE 443         KLS MARTIN GROUP: COMPANY OVERVIEW     411

12.2.5    SCANLAN INTERNATIONAL, INC.           412

TABLE 444         SCANLAN INTERNATIONAL, INC.: COMPANY OVERVIEW              412

12.2.6    WEXLER SURGICAL       413

TABLE 445         WEXLER SURGICAL: COMPANY OVERVIEW        413

12.2.7    STRAUSS SURGICAL      414

TABLE 446         STRAUSS SURGICAL: COMPANY OVERVIEW       414

12.2.8    AMNOTEC INTERNATIONAL GMBH      415

TABLE 447         AMNOTEC INTERNATIONAL GMBH: COMPANY OVERVIEW              415

12.2.9    ENDOMED SYSTEMS GMBH      416

TABLE 448         ENDOMED SYSTEMS GMBH: COMPANY OVERVIEW       416

12.2.10  TROKAMED GMBH        417

TABLE 449         TROKAMED GMBH: COMPANY OVERVIEW        417

12.2.11  SURGICAL HOLDINGS  418

TABLE 450         SURGICAL HOLDINGS: COMPANY OVERVIEW   418

*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.

13          APPENDIX         420

13.1       DISCUSSION GUIDE      420

13.2       KNOWLEDGESTORE: MARKETSANDMARKETS’  SUBSCRIPTION PORTAL             425

13.3       CUSTOMIZATION OPTIONS      427

13.4       RELATED REPORTS       427

13.5       AUTHOR DETAILS         428

MarketsandMarkets（マーケッツアンドマーケッツ）は世界中の企業に高い評価を得ており、著名メディアでの引用頻度も高い、インドの最大手級の市場調査会社です。広範な市場を対象にした市場調査レポートを出版しています。

※MarketsandMarketsの調査レポートはほぼ全タイトルご注文後、最短3時間～12時間以内（営業日基準）にご納品可能です。

ライセンス別価格表

調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。

ライセンスタイプ1

ライセンスタイプ2

ライセンスタイプ3

ライセンスタイプ4

ミニレポート　※定性調査にフォーカスした調査レポートです。詳細はお問合せください。

ご購入に関するご案内

価格・納期について

• 価格
  • ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
• ライセンス
  • シングルユーザライセンス
    • 1名のみレポートファイルのご利用が可能です。
  • マルチユーザライセンス
    • 同一企業内（関連会社除く）5名までレポートファイルのご利用が可能です。
  • コーポレートライセンス
    • 同一企業および100％持株会社間・人数無制限でレポートファイルのご利用が可能です。
  • エンタープライズサイトライセンス
    • 特別ライセンスです。適用範囲についてはお問合せください。
• 納品形態
  • Eメール
• 納期
  • 最短3時間以内にご納品可能です。通常ご注文後24時間以内（営業日基準）

ご注文方法

• レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。

その他

• 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。

株式会社SEMABIZはMarketsandMarketsの日本に拠点をおく販売代理店として、MarketsandMarketsのレポートを販売しております。サンプルページのご依頼、見積り、レポートに関するご質問など購入前のご相談はいつでもお気軽にご連絡ください。

最新調査レポート

• データセンターUPS市場規模、シェア、動向、2030年までの世界予測 2025-10-31
• 高純度ガス市場規模、シェア、動向、2030年までの世界予測 2025-10-30
• 動物用生物学的製剤市場規模、シェア、動向、2030年までの世界予測 2025-10-30
• エンジニアリング樹脂向け難燃剤市場規模、シェア、動向、2030年までの世界予測 2025-10-29
• アプリケーションモダナイゼーションサービス市場規模、シェア、動向、2031年までの世界予測 2025-10-29

MarketsandMarkets  出版レポート一覧